Microdialysis study of the neuropharmacokinetics of phenytoin in rat hippocampus and frontal cortex

Epilepsia

Volumn 37, Issue 5, 1996, Pages 421-427

  Walker, M C ^a   Alavijeh, M S ^a   Shorvon, S D ^a   Patsalos, P N ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Brain extracellular fluid; Microdialysis; Phenytoin; Status epilepticus

Indexed keywords

PHENYTOIN;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DISTRIBUTION; EPILEPTIC STATE; EXTRACELLULAR MATRIX; FRONTAL CORTEX; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; EXTRACELLULAR SPACE; FRONTAL LOBE; HIPPOCAMPUS; MALE; MICRODIALYSIS; PHENYTOIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0029877361     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1996.tb00586.x     Document Type: Article

References (38)

1. Leppik IE, Patrick BK, Cranford RE. Treatment of acute seizures and status epilepticus with intravenous phenytoin. Adv Neurol 1983;34:447-52.
2. Wilder BJ, Ramsay RE, Willmore LJ, Feussner GF, Perchalski RJ, Shumate JB Jr. Efficacy of intravenous phenytoin in the treatment of status epilepticus, kinetics of central nervous system penetration. Ann Neurol 1977;1:511-8.
3. Shorvon SD. Tonic clonic status epilepticus. J Neurol Neurosurg Psychiatry 1993;56:125-34.
4. Wallis W, Kutt H, McDowell F. IV diphenylhydantoin in treatment of acute repetitive seizures. Neurology 1968;18: 513-25.
5. 11C-labeled diphenylhydantoin: positron emission tomography in humans. Neurology 1983;33:580-5.
6. Firemark H, Barlow CF, Roth LJ. The entry accumulation and binding of diphenylhydrantoin-2-C14 in brain. Studies on adult, immature and hypercapnic cats. Int J Neuropharmacol 1963;2:25-38.
7. Geary II WA, Wooten GF, Perlin JB, Lothman EW. In vitro and in vivo distribution and binding of phenytoin to rat brain. J Pharmacol Exp Ther 1987;241:704-13.
8. Goldberg MA, Phenytoin: binding. Adv Neurol 1980;27:323-37.
9. Houghton GW, Richens A, Toselund PA, Davidson S, Falconer MA. Brain concentrations of phenytoin, phenobarbitone and primidone in epileptic patients. Eur J Clin Pharmacol 1975;9:73-8.
10. Kemp JW, Woodbury DM. Subcellular distribution of 4-14 C-diphenylhydantoin in rat brain. J Pharmacol Exp Ther 1971;177:342-9.
11. Nakamura K, Masuda U, Nakatsuji K, Kiroka T. Comparative studies on the distribution and metabolic fate of diphenylhydantoin and 3-ethylcarbonyldiphenylhydantoin (P-6127) after chronic administration to dogs and cats. Naunyn Schmiedebergs Arch Pharmacol 1966;254:406-17.
12. Ramsay RE, Hammond EJ, Perchalski RJ, Wilder BJ. Brain uptake of phenytoin, phenobarbital and diazepam. Arch Neurol 1979;36:535-9.
13. Sechi G, Petruzzi V, Rosati G, et al. Brain interstitial fluid and intracellular distribution of phenytoin. Epilepsia 1989; 30:235-9.
14. Vajda F, Williams FM, Davidson S, Falconer MA, Breckenridge A. Human brain, cerebrospinal fluid and plasma concentration of diphenylhydantoin and phenobarbital. Clin Pharmacol Ther 1974;15:597-603.
15. Sechi GP, Russo A, Rosati G, Mutani R, Monaco F. Distribution of diphenylhydantoin in the brain during experimental status epilepticus of the cat. Epilepsy Res 1987;1:173-7.
16. Ramzan I, Levy G. Relationship between concentration and anticonvulsant effect of phenytoin against electroshock-induced seizures in rats: comparison of sampling sites for concentration determinations. J Pharm Sci 1989;78:448-51.
17. Alavijeh MS, Abed WT, O'Connell MT, Patsalos PN. A comparison of classical and microdialysis sampling techniques: a study of carbamazepine (CBZ) pharmacokinetics. Epilepsia 1993;34(suppl 2):76.
18. Bradberry CW, Nobiletti JB, Elsworth JD, Murphy B, Jatlow P, Roth RH. Cocaine and cocaethylene: microdialysis comparison of brain drug levels and effects on dopamine and serotonin. J Neurochem 1993;60:1429-35.
19. Dubey RK, McAllister CB, Inoue M, Wilkinson GR. Plasma binding and transport of diazepam across the blood-brain barrier. J Clin Invest 1989;84:1155-9.
20. Hurd YL, Kehr J, Ungerstedt U. In vivo microdialysis as a technique to monitor drug transport: correlation of extracellular cocaine levels and dopamine overflow in the rat brain. J Neurochem 1988;51:1314-6.
21. Lunte CE, Scott DO, Kissinger PT. Sampling living systems using microdialysis probes. Anal Chem 1991;63:733A-80A.
22. Scott DO, Sorenson LR, Steele KL, Pucket DL, Lunte CE. In vivo microdialysis sampling for pharmacokinetic investigations. Pharm Res 1991;128:389-92.
23. Stahle L, Segersvard S, Ungerstedt U. Drug distribution studies with microdialysis. II. Caffeine and theophylline in blood, brain and other tissue in rats. Life Sci 1991;49:1843-52.
24. Allen DD, Crooks PA, Yokel RA. 4-Trimethylammonium antipyrine: a quarternary ammoniun nonradionuclide marker for blood-brain barrier integrity during in vivo microdialysis. J Pharmacol Toxicol Methods 1992;28:129-35.
25. Benveniste H. Brain microdialysis. J Neurochem 1989;52: 1667-78.
26. Tossman U, Ungerstedt U. Microdialysis in the study of extracellular levels of amino acids in the rat brain. Acta Physiol Scand 1986;128:9-14.
27. Patsalos PN, Abed WT, Alavijeh MS, O'Connell MT. The use of microdialysis for the study of drug kinetics: some methodological considerations illustrated with antipyrine in rat frontal cortex. Br J Pharmacol 1995;115:503-9.
28. Hutson PH, Sarna GS, Kantamaneni BD, Curzon G. Monitoring the effect of a tryptophan load on brain indole metabolism in freely moving rats by simultaneous cerebrospinal fluid monitoring and brain dialysis. J Neurochem 1985;44: 1266-74.
29. Paxinos G, Watson C. The rat brain in stereotaxic coordinates, 2nd ed. San Diego: Academic Press, 1986.
30. Patsalos PN, Alavijeh MS, Semba J, Lolin YI. A freely moving and behaving rat model for the chronic and simultaneous study of drug pharmacokinetics (blood) and neuropharmacokinetics (cerebrospinal fluid): haematological and biochemical characterization and kinetic evaluation using carbamazepine. J Pharmacol Toxicol Methods 1992;28:21-8.
31. Ratnaraj N, Goldberg VD, Hjelm M. Temperature effects on the estimation of the free levels of phenytoin, carbamazepine, and phenobarbitone. Ther Drug Monit 1990;12:465-72.
32. Woodbury DM. Phenytoin: absorption, distribution and excretion. In: Levy R, Mattson R, Meldrum B, Penry JK, Dreifuss FE. eds. Antiepileptic drugs. New York: Raven Press, 1989:191-207.
33. Lolin YI, Ratnaraj N, Hjelm M, Patsalos PN. Antiepileptic drug pharmacokinetics and neuropharmacokinetics in individual rats by repetitive withdrawal of blood and cerebrospinal fluid: phenytoin. Epilepsy Res 1994;19:99-110.
34. Vicuna A, Lalka D, DuSouich P, Vicuna N, Ludden TM, McLean AJ. Dose-dependence of the apparent half-life of phenytoin in the rat. Res Commun Chem Pathol Pharmacol 1980;28:3-11.
35. Sherwin AL, Eisen AA, Sokolowski CD. Anticonvulsant drugs in human epileptogenic brain. Correlation of phenobarbital and diphenylhydantoin levels with plasma. Arch Neurol 1973;29:73-7.
36. Sironi VA, Cabrini G, Porro MG, Ravagnati L, Marossero F. Antiepileptic drug distribution in cerebral cortex: Ammon's horn and amygdala in man. J Neurosurg 1980;52:686-92.
37. Patsalos PN, Nagaki S, Doheny MH. Regional brain glycine neuropharmacokinetics after the administration of milacemide: an antiepileptic glycine prodrug. Curr Separations 1993;12(suppl 2):79.
38. Ramzan I. Pharmacodynamics of phenytoin-induced ataxia in rats. Epilepsy Res 1990;5:80-3.